Drugs / 1-13 Carbon Leucine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03371680 | Oct 2010 → Dec 2013 | adult acute respiratory distress syndrome, infectious disease with sepsis | University of Padova | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1-13 Carbon Leucine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03371680 ↗ |
| Route | Intravenous | “constant intravenous infusion” NCT03371680 ↗ |